Welltower stock
WELLNYSEWelltower Inc., Real EstateISIN US95040Q1040
60Score 60 out of 100, Neutral
Price and trend
84 / 100
Price history
+28% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 11% above it.
Since March 2023 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 58).
The price is 2.8% below its 52-week high. Largest decline in 20 years: 64% (September 2019 to March 2020).
Chart figures for advanced users
- SMA 50$234.47
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$221.16
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)58
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$181.96
- The lowest closing price of the last twelve months.
- Resistance$252.07
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Welltower Inc. belongs to the REIT (Healthcare Facilities) industry (United States) and, with a market value of $179.68B, is the largest of 18 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $10.67B (up 35.8% year on year) and earnings of $936.85M (down 1.6%).
- For fiscal 2026, analysts expect on average revenue of $14.31B (up 34.1%) and adjusted earnings per share of $2.83 (up 100.5%).
Show more
- MEQIRI Score 60 out of 100 (Neutral): rank 97 of 327 in Real Estate, median 55.
- The P/E is 109.8 (REIT (Healthcare Facilities) median 14.5, own median of recent years 50.6).
- For real estate investment trusts (REITs) what counts is funds from operations (FFO and AFFO). The P/E and the payout ratio of earnings say little here, because depreciation on properties depresses earnings.
- Our model puts fair value at $131.23, with the price 88% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Growing faster than its industryRevenue up 18.4% a year since 2020, REIT (Healthcare Facilities) median 10.2%.Growth 67
- Consistently profitableProfit in all 10 fiscal years from 2016 to 2025.Fundamentals 79
- Earnings turn into cashFree cash flow 136% of earnings over the last 12 months.Fundamentals 79
Weaknesses
- Interest barely coveredOperating profit covers interest only 0.3 times.Stability 68
- Richly valuedP/E 109.8, REIT (Healthcare Facilities) median 14.5, own median 50.6.Valuation 16
- DilutionShare count up 60% since 2020.Capital allocation 23
Its standout strengths are technical analysis and momentum, while capital allocation and valuation hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Fundamentals are strong, with stable profits and strong cash generation.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among the 100 largest stocks.
From 2016 to 2025, 7 in 100 such stocks fell 30% or more within a year, against a group average of 9 in 100.
What lowers it
- price near its 52-week high
- solid fundamentals
Valuation
Valuation signal
Significantly overvaluedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $93.74 and expensive above $218.72 (uncertainty high, one part of the fair value is more than twice the other).
The two parts of the fair value come to $194.94 (cash-flow model) and $67.53 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.
Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $113.43, at 7.8% it would be $158.07.
Valuation metrics
Half from the cash-flow model, half from operating cash flow per share times the median price to cash flow of the REIT industry (14.5). For the fair value, FFO only counts when it is in line with operating cash flow. That is not the case here, for example because the REIT carries its properties at market value, records little depreciation or a gain on sale sits in earnings. The cash-flow model uses AFFO: operating cash flow less maintenance, estimated at 4% of revenue. New construction and acquisitions do not count as running costs there.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 40.5% on the twelve months before. Revenue has grown strongly since 2006, at around 21% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 39%, operating 3%, net 9%.
Debt & balance sheet
latest quarterDebt is moderate, but interest coverage is weak. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 9 Feb 2027in 89 days
- Last reported
- 26 Oct 2026EPS reported $0.54 (expected $0.64)below expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $2.83−1.1%
- Revenue
- $14.31B+0.6%
- Earnings per share
- $3.27+0.6%
- Revenue
- $16.56B+1.7%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook raised
Share price after the results: −5.6%Welltower raised the midpoint of its 2026 FFO guidance by $0.10 to $6.50 per share, implying 23% growth, and lifted its full-year same-store NOI growth assumption to 15% to 16.25%.
“These results, coupled with momentum that we are carrying into the fourth quarter, enabled us to raise the midpoint of our full year FFO outlook by 10¢ per share to $6.50 which if achieved, would represent a 23% year over year growth.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 27 Oct 2026 (fiscal Q3 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
One insider bought on the open market in the last 6 months, $2.41M in total.
Partial trades from one filing are shown in one row, with the average price.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Welltower
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
327 rated companies in Real Estate
- This company
- 60
- Sector median
- 55
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in REIT (Healthcare Facilities)
The next smaller companies by market value
- VentasVTR $47.82B47
- Omega Healthcare InvestorsOHI $14.64B67
- Healthpeak PropertiesDOC $14.05B53
- American Healthcare REITAHR $13B56
- CareTrust REITCTRE $9.95B67
- Healthcare Realty TrustHR $6.68B46
- AedificaAED.BR $6.09B62
- Sabra Health Care REITSBRA $5.49B50
ETFs that hold Welltower
Held by 117 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| VanEck Global Real Estate UCITS ETFTRET | 12.52% | 0.25% | €475.2M |
| State Street SPDR Dow Jones Global Real Estate UCITS ETF (Acc)SPY2 | 10.42% | 0.40% | €52.83M |
| Amundi FTSE EPRA NAREIT Global UCITS ETF Dist10AJ | 8.84% | 0.24% | €603.52M |
Show 5 more
| HSBC FTSE EPRA NAREIT Developed UCITS ETFH4ZL | 8.71% | 0.24% | €3.36B |
| UBS FTSE EPRA Nareit Developed Green UCITS ETF USD disCSYZ | 6.37% | 0.25% | €207.23M |
| iShares Edge MSCI USA Minimum Volatility Advanced UCITS ETFMVEA | 1.54% | 0.20% | €117.82M |
| iShares Edge MSCI USA Momentum Factor UCITS ETFQDVA | 1.50% | 0.20% | €515.17M |
| iShares Edge MSCI World Minimum Volatility Advanced UCITS ETF USD (Acc)MVEW | 1.13% | 0.30% | €306.37M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 29 Feb 2024)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.